• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道菌群-宿主-伊立替康轴:伊立替康化疗的新见解。

Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy.

机构信息

The MOE Key Laboratory of Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines, and the SATCM Key Laboratory of New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine (SHUTCM), Shanghai, China.

出版信息

Front Cell Infect Microbiol. 2021 Oct 14;11:710945. doi: 10.3389/fcimb.2021.710945. eCollection 2021.

DOI:10.3389/fcimb.2021.710945
PMID:34722328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8553258/
Abstract

Irinotecan (CPT11) and its active metabolite ethyl-10-hydroxy-camptothecin (SN38) are broad-spectrum cytotoxic anticancer agents. Both cause cell death in rapidly dividing cells (e.g., cancer cells, epithelial cells, hematopoietic cells) and commensal bacteria. Therefore, CPT11 can induce a series of toxic side-effects, of which the most conspicuous is gastrointestinal toxicity (nausea, vomiting, diarrhea). Studies have shown that the gut microbiota modulates the host response to chemotherapeutic drugs. Targeting the gut microbiota influences the efficacy and toxicity of CPT11 chemotherapy through three key mechanisms: microbial ecocline, catalysis of microbial enzymes, and immunoregulation. This review summarizes and explores how the gut microbiota participates in CPT11 metabolism and mediates host immune dynamics to affect the toxicity and efficacy of CPT11 chemotherapy, thus introducing a new concept that is called "microbiota-host-irinotecan axis". Also, we emphasize the utilization of bacterial β-glucuronidase-specific inhibitor, dietary interventions, probiotics and strain-engineered interventions as emergent microbiota-targeting strategies for the purpose of improving CPT11 chemotherapy efficiency and alleviating toxicity.

摘要

伊立替康(CPT11)及其活性代谢物乙基-10-羟基喜树碱(SN38)是广谱细胞毒性抗癌药物。两者都会导致快速分裂的细胞(例如癌细胞、上皮细胞、造血细胞)和共生细菌死亡。因此,CPT11 可引起一系列毒性副作用,其中最明显的是胃肠道毒性(恶心、呕吐、腹泻)。研究表明,肠道微生物群调节宿主对化疗药物的反应。通过三种关键机制靶向肠道微生物群可以影响 CPT11 化疗的疗效和毒性:微生物生态变化、微生物酶的催化作用和免疫调节。这篇综述总结并探讨了肠道微生物群如何参与 CPT11 代谢并介导宿主免疫动态,从而影响 CPT11 化疗的毒性和疗效,从而引入了一个新概念,称为“微生物群-宿主-伊立替康轴”。此外,我们强调利用细菌β-葡萄糖醛酸酶特异性抑制剂、饮食干预、益生菌和经过工程改造的菌株干预作为新兴的微生物群靶向策略,以提高 CPT11 化疗的效率并减轻毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0559/8553258/73edcb5078d4/fcimb-11-710945-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0559/8553258/c8632f2c1cb9/fcimb-11-710945-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0559/8553258/b5568010db6c/fcimb-11-710945-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0559/8553258/73edcb5078d4/fcimb-11-710945-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0559/8553258/c8632f2c1cb9/fcimb-11-710945-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0559/8553258/b5568010db6c/fcimb-11-710945-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0559/8553258/73edcb5078d4/fcimb-11-710945-g003.jpg

相似文献

1
Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy.肠道菌群-宿主-伊立替康轴:伊立替康化疗的新见解。
Front Cell Infect Microbiol. 2021 Oct 14;11:710945. doi: 10.3389/fcimb.2021.710945. eCollection 2021.
2
Berberine Improves Irinotecan-Induced Intestinal Mucositis Without Impairing the Anti-colorectal Cancer Efficacy of Irinotecan by Inhibiting Bacterial β-glucuronidase.黄连素通过抑制细菌β-葡萄糖醛酸酶改善伊立替康诱导的肠道黏膜炎,且不损害伊立替康的抗结直肠癌疗效。
Front Pharmacol. 2021 Nov 2;12:774560. doi: 10.3389/fphar.2021.774560. eCollection 2021.
3
Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity.伊立替康与肠道微生物群的相互作用以及益生菌减轻伊立替康相关毒性的能力。
BMC Microbiol. 2023 Mar 2;23(1):53. doi: 10.1186/s12866-023-02791-3.
4
Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy.靶向抑制肠道细菌β-葡萄糖醛酸酶活性可增强抗癌药物疗效。
Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7374-7381. doi: 10.1073/pnas.1918095117. Epub 2020 Mar 13.
5
Carboxylesterase isoform 2 mRNA expression in peripheral blood mononuclear cells is a predictive marker of the irinotecan to SN38 activation step in colorectal cancer patients.外周血单个核细胞中羧酸酯酶同工型2信使核糖核酸的表达是结直肠癌患者中伊立替康向SN38激活步骤的一个预测标志物。
Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6901-7. doi: 10.1158/1078-0432.CCR-05-0602.
6
Opioid-induced microbial dysbiosis disrupts irinotecan (CPT-11) metabolism and increases gastrointestinal toxicity in a murine model.阿片类药物诱导的微生物失调破坏伊立替康(CPT-11)代谢并增加小鼠模型中的胃肠道毒性。
Br J Pharmacol. 2023 May;180(10):1362-1378. doi: 10.1111/bph.16020. Epub 2023 Jan 9.
7
Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy.肠道微生物群与癌症:肠道微生物群如何调节抗肿瘤治疗的活性、疗效和毒性。
Crit Rev Oncol Hematol. 2019 Nov;143:139-147. doi: 10.1016/j.critrevonc.2019.09.003. Epub 2019 Sep 20.
8
A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery.一种基于分子的伊立替康昼夜递药优化的联合实验和数学方法。
PLoS Comput Biol. 2011 Sep;7(9):e1002143. doi: 10.1371/journal.pcbi.1002143. Epub 2011 Sep 8.
9
Gut microbiota modulation of chemotherapy efficacy and toxicity.肠道微生物群调节化疗疗效和毒性。
Nat Rev Gastroenterol Hepatol. 2017 Jun;14(6):356-365. doi: 10.1038/nrgastro.2017.20. Epub 2017 Mar 8.
10
[Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?].[5-氟尿嘧啶与亚叶酸联合应用——它仍是晚期结直肠癌的标准治疗方法吗?]
Tumori. 2000 Sep-Oct;86(5 Suppl 2):S19-25.

引用本文的文献

1
Gut microbiota in gastric cancer: from pathogenesis to precision medicine.胃癌中的肠道微生物群:从发病机制到精准医学
Front Microbiol. 2025 Jul 30;16:1606924. doi: 10.3389/fmicb.2025.1606924. eCollection 2025.
2
Comparative Analysis of Gut Microbiota Responses to New SN-38 Derivatives, Irinotecan, and FOLFOX in Mice Bearing Colorectal Cancer Patient-Derived Xenografts.携带结直肠癌患者来源异种移植瘤的小鼠肠道微生物群对新型SN-38衍生物、伊立替康和FOLFOX反应的比较分析
Cancers (Basel). 2025 Jul 7;17(13):2263. doi: 10.3390/cancers17132263.
3
Modulation of gut microbiota and immune response by soy peptides mitigates irinotecan induced intestinal toxicity.

本文引用的文献

1
Role of gut microbiome in the outcome of cancer immunotherapy.肠道微生物群在癌症免疫治疗结果中的作用。
Int J Cancer. 2021 Feb 18. doi: 10.1002/ijc.33524.
2
A systematic review of gut microbiome and ocular inflammatory diseases: Are they associated?肠道微生物组与眼部炎症性疾病的系统评价:它们有关联吗?
Indian J Ophthalmol. 2021 Mar;69(3):535-542. doi: 10.4103/ijo.IJO_1362_20.
3
Lactobacillus Kefiri LKF01 (Kefibios) for Prevention of Diarrhoea in Cancer Patients Treated with Chemotherapy: A Prospective Study.科菲尔乳杆菌 LKF01(科菲 Bios)预防化疗癌症患者腹泻:一项前瞻性研究。
大豆肽对肠道微生物群和免疫反应的调节减轻了伊立替康诱导的肠道毒性。
Front Physiol. 2025 Jun 3;16:1538733. doi: 10.3389/fphys.2025.1538733. eCollection 2025.
4
A pilot study of gut mucosal and faecal microbiota in rectal cancer: associations with histological response and adverse events following preoperative chemoradiotherapy.直肠癌患者肠道黏膜和粪便微生物群的一项初步研究:与术前放化疗后的组织学反应及不良事件的关联
Colorectal Dis. 2025 May;27(5):e70106. doi: 10.1111/codi.70106.
5
β-Glucuronidase-Expressing Lactobacillus reuteri Triggers Irinotecan Enterotoxicity Through Depleting the Regenerative Epithelial Stem/Progenitor Pool.表达β-葡萄糖醛酸酶的罗伊氏乳杆菌通过耗尽再生上皮干细胞/祖细胞池引发伊立替康肠毒性。
Adv Sci (Weinh). 2025 Apr 26:e2411052. doi: 10.1002/advs.202411052.
6
Phytochemicals in Cancer Therapy: A Structured Review of Mechanisms, Challenges, and Progress in Personalized Treatment.植物化学物质在癌症治疗中的应用:个性化治疗机制、挑战及进展的结构化综述
Chem Biodivers. 2025 Aug;22(8):e202402479. doi: 10.1002/cbdv.202402479. Epub 2025 Jun 11.
7
Role of gut microbiota in predicting chemotherapy-induced neutropenia duration in leukemia patients.肠道微生物群在预测白血病患者化疗引起的中性粒细胞减少持续时间中的作用。
Front Microbiol. 2025 Mar 19;16:1507336. doi: 10.3389/fmicb.2025.1507336. eCollection 2025.
8
Managing Irinotecan-Induced Diarrhea: A Comprehensive Review of Therapeutic Interventions in Cancer Treatment.管理伊立替康所致腹泻:癌症治疗中治疗干预措施的全面综述
Pharmaceuticals (Basel). 2025 Mar 2;18(3):359. doi: 10.3390/ph18030359.
9
Targeted inhibition of Gus-expressing to promote intestinal stem cell and epithelial renovation contributes to the relief of irinotecan chemotoxicity by dehydrodiisoeugenol.靶向抑制表达Gus的细胞以促进肠道干细胞和上皮更新,有助于减轻脱氢二异丁香酚对伊立替康化学毒性的缓解作用。
Acta Pharm Sin B. 2024 Dec;14(12):5286-5304. doi: 10.1016/j.apsb.2024.09.018. Epub 2024 Oct 18.
10
Microbiome and Mucosal Immunity in the Intestinal Tract.肠道中的微生物群与黏膜免疫
In Vivo. 2025 Jan-Feb;39(1):17-24. doi: 10.21873/invivo.13801.
Nutrients. 2021 Jan 27;13(2):385. doi: 10.3390/nu13020385.
4
Modulation of the immune response and metabolism in germ-free rats colonized by the probiotic Lactobacillus salivarius LI01.唾液乳杆菌LI01定殖的无菌大鼠免疫反应和代谢的调节
Appl Microbiol Biotechnol. 2021 Feb;105(4):1629-1645. doi: 10.1007/s00253-021-11099-z. Epub 2021 Jan 19.
5
Transcriptome of Lactobacillus acidophilus and Colonization Impact on Murine Host Intestinal Gene Expression.嗜酸乳杆菌转录组及其对小鼠宿主肠道基因表达的定植影响。
mBio. 2021 Jan 26;12(1):e03399-20. doi: 10.1128/mBio.03399-20.
6
The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants.癌症微生物组图谱:一种泛癌症比较分析,用于区分组织驻留微生物群与污染物。
Cell Host Microbe. 2021 Feb 10;29(2):281-298.e5. doi: 10.1016/j.chom.2020.12.001. Epub 2021 Jan 6.
7
The impact of modulating the gastrointestinal microbiota in cancer patients.调节癌症患者的胃肠道微生物群的影响。
Best Pract Res Clin Gastroenterol. 2020 Oct-Dec;48-49:101700. doi: 10.1016/j.bpg.2020.101700. Epub 2020 Oct 19.
8
Effects of dietary fibre intake in chemotherapy-induced mucositis in murine model.膳食纤维摄入对化疗诱导的小鼠模型黏膜炎的影响。
Br J Nutr. 2021 Sep 28;126(6):853-864. doi: 10.1017/S0007114520004924. Epub 2020 Dec 10.
9
Enhancing anti-tumour efficacy with immunotherapy combinations.免疫疗法联合增强抗肿瘤疗效。
Lancet. 2021 Mar 13;397(10278):1010-1022. doi: 10.1016/S0140-6736(20)32598-8. Epub 2020 Dec 4.
10
The gut microbiota is associated with immune cell dynamics in humans.肠道微生物群与人类免疫细胞动力学有关。
Nature. 2020 Dec;588(7837):303-307. doi: 10.1038/s41586-020-2971-8. Epub 2020 Nov 25.